Unifuse Catheter Availability and Pricing in India
I cannot provide specific pricing or company availability information for the Unifuse catheter in India, as the provided evidence does not contain this commercial data.
What the Evidence Shows About Unifuse Catheters
The Unifuse catheter is a catheter-directed lysis (CDL) device manufactured by AngioDynamics Inc (Latham, NY, USA) that has FDA 510(k) clearance for treatment of peripheral vasculature, not specifically for pulmonary embolism. 1
Technical Specifications
- The Unifuse is a 4F-5F catheter used for catheter-directed thrombolysis 1
- It functions as a simple infusion catheter with multiple ports along its length for local thrombolytic delivery 1
- Operators typically use infusion lengths of 5-10 cm depending on thrombus burden 1
Clinical Context
- The Unifuse catheter is commonly used alongside the Cragg-McNamara catheter (ev3 Inc, Plymouth, MN) as standard CDL devices for pulmonary embolism treatment 1
- Both catheters carry FDA indication for peripheral vasculature infusion without specific PE indication 1
Obtaining Pricing Information in India
To obtain actual pricing and availability in India, you should:
- Contact AngioDynamics Inc directly or their authorized Indian distributors
- Check with major tertiary care hospitals in India that perform interventional procedures
- Consult with interventional radiology or cardiology departments at teaching hospitals
- Review Indian medical device import regulations and pricing databases maintained by healthcare institutions
Important Caveat
The evidence provided focuses on clinical applications in pulmonary embolism treatment rather than commercial availability. India's medical device pricing landscape varies significantly by institution, import regulations, and distributor agreements, making it impossible to provide accurate pricing without current commercial data. 1